Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$11.84 USD
+0.04 (0.30%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $11.84 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Dynavax Technologies Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 232 | 723 | 439 | 47 | 35 |
Cost Of Goods | 50 | 262 | 174 | 11 | 10 |
Gross Profit | 182 | 461 | 266 | 35 | 25 |
Selling & Adminstrative & Depr. & Amort Expenses | 219 | 177 | 131 | 104 | 160 |
Income After Depreciation & Amortization | -37 | 284 | 134 | -68 | -135 |
Non-Operating Income | 39 | 18 | -46 | 12 | -1 |
Interest Expense | 7 | 7 | 11 | 19 | 17 |
Pretax Income | -4 | 294 | 78 | -75 | -153 |
Income Taxes | 2 | 1 | 1 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -6 | 293 | 77 | -75 | -153 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -6 | 293 | 77 | -75 | -153 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -46 | 286 | 142 | -59 | -115 |
Depreciation & Amortization (Cash Flow) | -9 | 2 | 7 | 10 | 20 |
Income After Depreciation & Amortization | -37 | 284 | 134 | -68 | -135 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 128.73 | 150.80 | 133.01 | 101.50 | 72.02 |
Diluted EPS Before Non-Recurring Items | -0.05 | 1.97 | 0.87 | -0.61 | -1.87 |
Diluted Net EPS (GAAP) | -0.05 | 1.97 | 0.57 | -0.78 | -2.16 |
Fiscal Year end for Dynavax Technologies Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 55.60 | 69.51 | 60.25 | 46.93 |
Cost Of Goods | NA | 8.69 | 13.23 | 13.54 | 14.71 |
Gross Profit | NA | 46.91 | 56.29 | 46.71 | 32.21 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 55.40 | 51.17 | 50.12 | 62.47 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -8.49 | 5.12 | -3.41 | -30.26 |
Non-Operating Income | NA | 11.18 | 10.72 | 9.30 | 8.22 |
Interest Expense | NA | 1.69 | 1.69 | 1.69 | 1.69 |
Pretax Income | NA | 1.00 | 14.15 | 4.21 | -23.72 |
Income Taxes | NA | 0.78 | -0.15 | 0.78 | 0.62 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 0.22 | 14.29 | 3.43 | -24.33 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 0.22 | 14.29 | 3.43 | -24.33 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 133.28 | 154.20 | 152.14 | 127.92 |
Diluted EPS Before Non-Recurring Items | NA | 0.00 | 0.10 | 0.03 | -0.19 |
Diluted Net EPS (GAAP) | NA | 0.01 | 0.10 | 0.03 | -0.19 |